On December 31, 2008, Regeneron Pharmaceuticals (REGN) had a market capitalization of $1.5B, based on 79.5M shares at a price of $18.28.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2008 | $18.28 | 9,741,000 | 79,498,000 | $1,453,350,636.80 |
November 2008 | $15.39 | 9,644,600 | 79,498,000 | $1,223,792,212.00 |
October 2008 | $19.22 | 14,289,100 | 79,498,000 | $1,527,760,764.80 |
September 2008 | $21.74 | 16,925,000 | 78,937,000 | $1,715,837,781.60 |
August 2008 | $21.63 | 12,932,400 | 78,937,000 | $1,707,194,180.10 |
July 2008 | $21.80 | 13,991,200 | 78,937,000 | $1,720,558,214.20 |
June 2008 | $14.38 | 17,958,600 | 78,689,000 | $1,131,421,917.60 |
May 2008 | $19.82 | 13,500,400 | 78,689,000 | $1,559,230,403.90 |
April 2008 | $19.54 | 9,983,300 | 78,689,000 | $1,537,284,041.80 |
March 2008 | $19.11 | 16,952,800 | 78,493,000 | $1,499,852,093.30 |
February 2008 | $19.69 | 11,527,800 | 78,493,000 | $1,545,181,800.80 |
January 2008 | $20.19 | 13,352,500 | 78,493,000 | $1,585,040,546.20 |
December 2007 | $24.05 | 12,706,300 | 78,493,000 | $1,887,513,321.70 |
November 2007 | $21.69 | 16,213,100 | 78,493,000 | $1,702,277,691.00 |
October 2007 | $21.91 | 15,354,300 | 78,493,000 | $1,719,475,507.30 |
September 2007 | $17.72 | 13,533,100 | 66,069,000 | $1,171,006,956.00 |
August 2007 | $19.38 | 24,471,500 | 66,069,000 | $1,280,212,406.10 |
July 2007 | $14.83 | 13,226,800 | 66,069,000 | $979,565,421.60 |
June 2007 | $17.84 | 28,420,800 | 65,950,000 | $1,176,778,825.00 |
May 2007 | $22.34 | 22,373,600 | 65,950,000 | $1,473,599,990.00 |
April 2007 | $27.08 | 16,149,100 | 65,950,000 | $1,786,183,205.00 |
March 2007 | $21.53 | 15,081,600 | 65,563,000 | $1,411,420,595.10 |
February 2007 | $19.76 | 12,044,600 | 65,563,000 | $1,295,216,733.90 |
January 2007 | $19.81 | 9,997,800 | 65,563,000 | $1,298,481,771.30 |
December 2006 | $19.98 | 9,467,700 | 65,563,000 | $1,310,230,660.90 |
